Financials
- Market Capitalization 20.62 M
- Employee 7
- Founded 2004
- CEO N/A
- Website www.lexariabioscience.com
- Headquarter Nevada, United States
- FIGI BBG000JQHT18
- Industry Biotecnología
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.12
Relación precio/flujo de caja
58.78
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4527 | COCP Cocrystal Pharma, Inc. - Common Stock | 1.12 USD | -3.45% | -0.88% | +28.74% | -23.29% | 21.57 M USD | ||
| 4529 | LGVN Longeveron Inc. - Class A Common stock | 6.75 USD | -2.17% | +878.26% | +850.70% | +1081.52% | 21.52 M USD | ||
| 4542 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 12.63 USD | -8.28% | -8.41% | -1.33% | +115.90% | 20.45 M USD | ||
| 4544 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.79 USD | +0.80% | -1.81% | -1.81% | -68.42% | 20.48 M USD |